seed
Stage
6
Investors
About
Nanordica Medical develops advanced antibacterial wound dressings using silk nanofibers and its Premotiv® nanotechnology to prevent infection and accelerate healing, with demonstrated efficacy in diabetic foot ulcer treatment through a randomized controlled trial.
Explore Nanordica Medical's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.